These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23346660)

  • 1. Striae distensae: the fibrillin/transforming growth factor beta signaling puzzle.
    de Lacerda D
    Skinmed; 2012; 10(6):338-40. PubMed ID: 23346660
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrillin in Marfan syndrome and tight skin mice provides new insights into transforming growth factor-beta regulation and systemic sclerosis.
    Lemaire R; Bayle J; Lafyatis R
    Curr Opin Rheumatol; 2006 Nov; 18(6):582-7. PubMed ID: 17053502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome.
    Ng CM; Cheng A; Myers LA; Martinez-Murillo F; Jie C; Bedja D; Gabrielson KL; Hausladen JM; Mecham RP; Judge DP; Dietz HC
    J Clin Invest; 2004 Dec; 114(11):1586-92. PubMed ID: 15546004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striae distensae after breast augmentation.
    Basile FV; Basile AV; Basile AR
    Aesthetic Plast Surg; 2012 Aug; 36(4):894-900. PubMed ID: 22538277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striae distensae: a comprehensive review and evidence-based evaluation of prophylaxis and treatment.
    Al-Himdani S; Ud-Din S; Gilmore S; Bayat A
    Br J Dermatol; 2014 Mar; 170(3):527-47. PubMed ID: 24125059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Edematous striae distensae.
    Kumar V; Iyengar SS
    Intern Emerg Med; 2012 Sep; 7 Suppl 2():S159-60. PubMed ID: 22492009
    [No Abstract]   [Full Text] [Related]  

  • 7. Determination of the molecular basis of Marfan syndrome: a growth industry.
    Byers PH
    J Clin Invest; 2004 Jul; 114(2):161-3. PubMed ID: 15254580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the latent transforming growth factor beta binding protein 1 in fibrillin-containing microfibrils in bone cells in vitro and in vivo.
    Dallas SL; Keene DR; Bruder SP; Saharinen J; Sakai LY; Mundy GR; Bonewald LF
    J Bone Miner Res; 2000 Jan; 15(1):68-81. PubMed ID: 10646116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular biological aspects of Marfan syndromes].
    Belsing TZ; Lund AM; Abildstrøm SZ; Søndergaard L; Friis-Hansen L
    Ugeskr Laeger; 2011 Jan; 173(5):333-7. PubMed ID: 21276395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marfan syndrome and mitral valve prolapse.
    Weyman AE; Scherrer-Crosbie M
    J Clin Invest; 2004 Dec; 114(11):1543-6. PubMed ID: 15578086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone lessons from Marfan syndrome and related disorders: fibrillin, TGF-B and BMP at the balance of too long and too short.
    Loeys BL; Mortier G; Dietz HC
    Pediatr Endocrinol Rev; 2013 Jun; 10 Suppl 2():417-23. PubMed ID: 23858625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striae distensae in adolescents: A mini review.
    Elsedfy H
    Acta Biomed; 2020 Mar; 91(1):176-181. PubMed ID: 32191678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do body build and composition influence striae distensae occurrence and visibility in women?
    Kasielska-Trojan A; Antoszewski B
    J Cosmet Dermatol; 2018 Dec; 17(6):1165-1169. PubMed ID: 29105985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic update on the treatment of striae distensae.
    Sarnoff DS
    J Drugs Dermatol; 2015 Jan; 14(1):11-2. PubMed ID: 25607902
    [No Abstract]   [Full Text] [Related]  

  • 15. Prematurity: is it a risk factor for striae distensae?
    Kelekci KH; Kelekci S; Destegul E; Aksoy A; Sut N; Yilmaz B
    Int J Dermatol; 2011 Oct; 50(10):1240-5. PubMed ID: 21585350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical application of 17beta-estradiol increases extracellular matrix protein synthesis by stimulating tgf-Beta signaling in aged human skin in vivo.
    Son ED; Lee JY; Lee S; Kim MS; Lee BG; Chang IS; Chung JH
    J Invest Dermatol; 2005 Jun; 124(6):1149-61. PubMed ID: 15955089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One more piece in the fibrillin puzzle.
    Hubmacher D; Reinhardt DP
    Structure; 2009 May; 17(5):635-6. PubMed ID: 19446519
    [No Abstract]   [Full Text] [Related]  

  • 18. Ulcerations in striae distensae.
    Leite LL; Bakos RM
    Australas J Dermatol; 2021 May; 62(2):e321-e322. PubMed ID: 33070310
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrillin controls TGF-beta activation.
    Kaartinen V; Warburton D
    Nat Genet; 2003 Mar; 33(3):331-2. PubMed ID: 12610545
    [No Abstract]   [Full Text] [Related]  

  • 20. Gene expression during chemically induced liver fibrosis: effect of halofuginone on TGF-beta signaling.
    Gnainsky Y; Kushnirsky Z; Bilu G; Hagai Y; Genina O; Volpin H; Bruck R; Spira G; Nagler A; Kawada N; Yoshizato K; Reinhardt DP; Libermann TA; Pines M
    Cell Tissue Res; 2007 Apr; 328(1):153-66. PubMed ID: 17180598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.